OR8S1, as a member of the olfactory receptor family, plays a crucial role in the detection and recognition of specific odorant molecules within the nasal epithelium. These receptors are integral to the sense of smell, functioning through the binding of volatile chemical compounds, which initiates a signal transduction pathway that ultimately results in the brain perceiving different scents. Specifically, OR8S1 contributes to the diversity and specificity of olfactory perception by recognizing and responding to unique odorant signatures. The activation of this receptor involves the binding of an odorant molecule to the receptor, which causes a conformational change in the receptor's structure, triggering a cascade of cellular events.
The activation of OR8S1 is highly dependent on the interaction between the receptor and its specific ligand. When an appropriate odorant molecule binds to OR8S1, it induces a change in the receptor's conformation, activating the G protein-coupled receptor (GPCR) signaling pathway. This activation leads to the exchange of GDP for GTP on the G protein, followed by the dissociation of the G protein into its alpha and beta-gamma subunits. These subunits then interact with downstream effectors, such as adenylate cyclase, which catalyzes the conversion of ATP to cyclic AMP (cAMP). The increase in cAMP opens ion channels, particularly calcium channels, leading to an influx of calcium ions into the cell. This influx creates an electrical signal that propagates along the olfactory sensory neurons, ultimately reaching the brain where the signal is interpreted as a distinct smell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor that prevents the degradation of cAMP, potentially amplifying the signal generated by OR8S1 upon odorant binding. | ||||||
O-1918 | 536697-79-7 | sc-202746 sc-202746A | 1 mg 5 mg | $61.00 $235.00 | ||
A selective antagonist of GPR18, but since ORs and GPCRs share signaling pathways, it might modulate the G protein-mediated transduction in OR8S1. | ||||||
(+)-Pilocarpine hydrochloride | 54-71-7 | sc-203196 sc-203196A sc-203196B | 1 g 100 g 10 g | $62.00 $3641.00 $520.00 | 3 | |
A muscarinic receptor agonist. Although it targets muscarinic receptors, its ability to influence GPCR pathways may indirectly affect OR8S1. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Vanilloid receptor agonist. As with Pilocarpine, its role in GPCR signaling might indirectly touch upon OR8S1 activity. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
PKC inhibitor that influences downstream GPCR signaling pathways, which can have indirect effects on OR8S1 activation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor affecting pathways downstream of GPCRs, potentially influencing OR8S1. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $138.00 $220.00 $972.00 | 47 | |
PKA inhibitor that can modulate cAMP-dependent pathways, influencing GPCR activity including OR8S1. | ||||||